TEMPE, Ariz.--(BUSINESS WIRE)--#Calviri--Calviri, Inc., a biotech startup focused on ending deaths from cancer, announces that Skysong Innovations, the intellectual property management company for ...

AUSTIN, Texas, April 28, 2025 /PRNewswire/ -- Genprex, Inc. (GNPX) ("Genprex" or the "Company") (NASDAQ: GNPX), a clinical-stage gene therapy company focused on developing life-changing therapies for ...

London UK, 4 April 2023 – Forcefield Therapeutics (“Forcefield”) Ltd, a pioneer of best-in-class therapeutics to protect heart function by arresting the loss of cardiomyocytes following myocardial ...

Hoth Therapeutics (HOTH) announced that it has entered into an exclusive patent license agreement with the U.S. Department of Veterans Affairs. This agreement provides Hoth with exclusive rights to a ...

The subject patent is co-owned by Genprex and UTHealth Houston, and the license provides Genprex with patent exclusivity. "We are pleased to expand our portfolio of licensed patents and add a ...

(RTTNews) - Hoth Therapeutics (HOTH) has entered into an exclusive patent license agreement with the U.S. Department of Veterans Affairs, providing the company with exclusive rights to a jointly owned ...

With volatile market conditions and recent FDA shakeups, biotech companies are increasingly focused on bolstering cash runways and accelerating R&D efforts. But fierce competition for financing has ...